Combination chemotherapy with L-asparaginase (EC-2) using P1798 lymphosarcoma.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001215:Asparaginase / Q000008:administration & dosage*; D001377:Azaserine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006846:Hydrocarbons, Halogenated / Q000008:administration & dosage; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D015122:Mercaptopurine / Q000008:administration & dosage; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D011239:Prednisolone / Q000008:administration & dosage; D012075:Remission, Spontaneous; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013852:Thiotepa / Q000008:administration & dosage; D013997:Time Factors; D014265:Triethylenemelamine / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D006846:Hydrocarbons, Halogenated; D003561:Cytarabine; D014750:Vincristine; D014747:Vinblastine; D001377:Azaserine; D003520:Cyclophosphamide; D013852:Thiotepa; D011239:Prednisolone; D015122:Mercaptopurine; D001215:Asparaginase; D014265:Triethylenemelamine; D005472:Fluorouracil; D003630:Daunorubicin